Table 3.
Characteristics of patients included in the educational program of the study1 n (%)
| Variable | Phase I (n = 1732) | Phase II (n = 1722) |
| Age (mean ± SD) | 61.06 ± 13.37 | 60.81 ± 13.89 |
| Female | 1038 (60.4) | 980 (57.6) |
| History of ulcer | 238 (13.7) | 307 (17.8) |
| History of ulcer bleeding | 61 (3.5) | 69 (4.0) |
| ASA use | 167 (9.6) | 168 (9.8) |
| CV history | 203 (11.7) | 205 (11.9) |
| Increased blood pressure | 845 (48.8) | 810 (47.0) |
| Anticoagulant use | 126 (7.3) | 120 (7.0) |
| Corticosteroid use | 162 (9.3) | 190 (11.0) |
| History of dyspepsia | 782 (45.1) | 766 (44.5) |
1
No statistical differences were found between patients enrolled in the two phases.
Phase I: Before physicians attended the evidence-based seminar; Phase II: After the seminar; ASA: Aspirin.